Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: Prevalence and risk factors

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 10, 2016, Pages 2957-2963

  Hamprecht, A ^a,b   Rohde, A M ^a,c   Behnke, M ^a,c   Feihl, S ^a,d   Gastmeier, P ^a,c   Gebhardt, F ^a,d   Kern, W V ^a,e   Knobloch, J K ^a,f   Mischnik, A ^a,e   Obermann, B ^a,f   Querbach, C ^a,d   Peter, S ^a,g   Schneider, C ^a,e   Schroder W ^a,h   Schwab, F ^a,c   Tacconelli, E ^a,h   Wiese Posselt, M ^a,c   Wille, T ^a,b   Willmann, M ^a,g   Seifert, H ^a,b   Zweigner, J ^a,b,c   Armean, Sabina ⁱ   Busch, Dirk ⁱ   Först, Gesche ⁱ   Foschi, Federico ⁱ   Gillis, Meyke ⁱ   Hansen, Dorothea ⁱ   Häcker, Georg ⁱ   Heim, Markus ⁱ   Hug, Martin ⁱ   Kaier, Klaus ⁱ   Kola, Axel ⁱ   Küpper, M Fabian ⁱ   Langebartels, Georg ⁱ   Liekweg, Andrea ⁱ   Lipp, Hans Peter ⁱ   Nordmann, Mathias ⁱ   Penadiaz, Luis Alberto ⁱ   Rupp, Jan ⁱ   Schneider, Christian ⁱ   Schröder, Christine ⁱ   Spohn, Katrin ⁱ   Steib Bauert, Michaela ⁱ   Vehreschild, Jörg J ⁱ   vor dem Esche, Ulrich ⁱ   more..

^a German Center of Infection Research   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^g UNIVERSITY OF TÜBINGEN   (Germany)

^h UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

ⁱ University Hospital Tübingen ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; MEROPENEM; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CEPHALOSPORIN RESISTANT ENTEROBACTERIACEAE; CITROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; GASTROESOPHAGEAL REFLUX; GERMANY; HAFNIA ALVEI; HOSPITAL ADMISSION; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PREVALENCE; PROSPECTIVE STUDY; PROTEUS MIRABILIS; QUESTIONNAIRE; RISK FACTOR; TRAVEL; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI INFECTIONS; GENETICS; HETEROZYGOTE; HOSPITALIZATION; ISOLATION AND PURIFICATION; LONG TERM CARE; MICROBIOLOGY; MIDDLE AGED; RECTUM;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CARRIER STATE; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI INFECTIONS; FEMALE; GERMANY; HOSPITALIZATION; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; PATIENT ADMISSION; PREVALENCE; PROSPECTIVE STUDIES; RECTUM; RISK FACTORS;

EID: 84994792049     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw216     Document Type: Article

References (38)

1. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother 2009; 64 Suppl 1: i3-10.
2. Woerther PL, Burdet C, Chachaty E et al. Trends in human fecal carriage of extended-spectrum b-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev 2013; 26: 744-58.
3. Frakking FN, Rottier WC, Dorigo-Zetsma JW et al. Appropriateness of empirical treatment and outcome in bacteremia caused by extendedspectrum-b-lactamase-producing bacteria. Antimicrob Agents Chemother 2013; 57: 3092-9.
4. Rottier WC, Ammerlaan HS, Bonten MJ. Effects of confounders and intermediates on the association of bacteraemia caused by extendedspectrum b-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis. J Antimicrob Chemother 2012; 67: 1311-20.
5. Tumbarello M, Spanu T, Di Bidino R et al. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrumb-lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother 2010; 54: 4085-91.
6. Luvsansharav UO, Hirai I, Nakata A et al. Prevalence of and risk factors associated with faecal carriage of CTX-M b-lactamase-producing Enterobacteriaceae in rural Thai communities. J Antimicrob Chemother 2012; 67: 1769-74.
7. Platteel TN, Leverstein-van Hall MA, Cohen Stuart JW et al. Predicting carriage with extended-spectrum b-lactamase-producing bacteria at hospital admission: a cross-sectional study. Clin Microbiol Infect 2015; 21: 141-6.
8. Seiffert SN, Hilty M, Kronenberg A et al. Extended-spectrum cephalosporin-resistant Escherichia coli in community, specialized outpatient clinic and hospital settings in Switzerland. J Antimicrob Chemother 2013; 68: 2249-54.
9. Kuenzli E, Jaeger VK, Frei R et al. High colonization rates of extendedspectrum b-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia: a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors. BMC Infect Dis 2014; 14: 528.
10. Leistner R, Meyer E, Gastmeier P et al. Risk factors associated with the community-acquired colonization of extended-spectrum b-lactamase (ESBL) positive Escherichia coli: an exploratory case-control study. PLoS One 2013; 8: e74323.
11. Seiffert SN, Hilty M, Perreten Vet al. Extended-spectrum cephalosporinresistant Gram-negative organisms in livestock: an emerging problem for human health? Drug Resist Updat 2013; 16: 22-45.
12. Giske CG, Martinez-Martinez L, Canton R et al. EUCAST Guideline for the Detection of Resistance Mechanisms and Specific Resistances of Clinical and/or Epidemiological Importance, Version 1.0, 2013. http://www. eucast.org/resistance:mechanisms/.
13. Polsfuss S, Bloemberg GV, Giger J et al. Practical approach for reliable detection of AmpC b-lactamase-producing Enterobacteriaceae. J Clin Microbiol 2011; 49: 2798-803.
14. Dallenne C, Da Costa A, Decre D et al. Development of a set of multiplex PCR assays for the detection of genes encoding important b-lactamases in Enterobacteriaceae. J Antimicrob Chemother 2010; 65: 490-5.
15. Eller C, Leistner R, Guerra B et al. Emergence of extended-spectrum b-lactamase (ESBL) CTX-M-8 in Germany. J Antimicrob Chemother 2014; 69: 562-4.
16. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC b-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40: 2153-62.
17. Doyle D, Peirano G, Lascols C et al. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J Clin Microbiol 2012; 50: 3877-80.
18. Valenza G, Nickel S, Pfeifer Y et al. Extended-spectrum-b-lactamaseproducing Escherichia coli as intestinal colonizers in the German community. Antimicrob Agents Chemother 2014; 58: 1228-30.
19. Wendt C, Lin D, von Baum H. Risk factors for colonization with third-generation cephalosporin-resistant Enterobacteriaceae. Infection 2005; 33: 327-32.
20. Kaspar T, Schweiger A, Droz S et al. Colonization with resistant microorganisms in patients transferred from abroad: who needs to be screened? Antimicrob Resist Infect Control 2015; 4: 31.
21. Shitrit P, Reisfeld S, Paitan Y et al. Extended-spectrum b-lactamaseproducing Enterobacteriaceae carriage upon hospital admission: prevalence and risk factors. J Hosp Infect 2013; 85: 230-2.
22. Young BE, Lye DC, Krishnan P et al. A prospective observational study of the prevalence and risk factors for colonization by antibiotic resistant bacteria in patients at admission to hospital in Singapore. BMC Infect Dis 2014; 14: 298.
23. D'Andrea MM, Arena F, Pallecchi L et al. CTX-M-type b-lactamases: a successful story of antibiotic resistance. Int J Med Microbiol 2013; 303: 305-17.
24. KaaseM. [Carbapenemases in Gram-negative bacteria. Current data and trends of resistance resulting from the work of national reference centres]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012; 55: 1401-4.
25. Canton R, Akova M, Carmeli Y et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012; 18: 413-31.
26. Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J et al. Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect 2011; 17: 873-80.
27. Jones RN, Flonta M, Gurler N et al. Resistance surveillance program report for selected European nations (2011). Diagn Microbiol Infect Dis 2014; 78: 429-36.
28. Levy SS, Mello MJ, Gusmao-Filho FA et al. Colonisation by extendedspectrum b-lactamase-producing Klebsiella spp. in a paediatric intensive care unit. J Hosp Infect 2010; 76: 66-9.
29. Ludden C, Cormican M, Vellinga A et al. Colonisation with ESBLproducing and carbapenemase-producing Enterobacteriaceae, vancomycinresistant enterococci, and meticillin-resistant Staphylococcus aureus in a long-term care facility over one year. BMC Infect Dis 2015; 15: 168.
30. Paltansing S, Vlot JA, Kraakman ME et al. Extended-spectrum b-lactamase-producing Enterobacteriaceae among travelers from the Netherlands. Emerg Infect Dis 2013; 19: 1206-13.
31. Tangden T, Cars O, Melhus A et al. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extendedspectrum b-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010; 54: 3564-8.
32. Hogardt M, Proba P, Mischler D et al. Current prevalence of multidrugresistant organisms in long-term care facilities in the Rhine-Main district, Germany, 2013. Euro Surveill 2015; 20: pii=21171.
33. Driks MR, Craven DE, Celli BR et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med 1987; 317: 1376-82.
34. Graham PL III, Begg MD, Larson E et al. Risk factors for late onset gramnegative sepsis in low birth weight infants hospitalized in the neonatal intensive care unit. Pediatr Infect Dis J 2006; 25: 113-7.
35. Jazmati N, Hein R, Hamprecht A. Use of an enrichment broth improves detection of extended-spectrum-b-lactamase-producing Enterobacteriaceae in clinical stool samples. J Clin Microbiol 2016; 54: 467-70.
36. Wilkinson KM, Winstanley TG, Lanyon C et al. Comparison of four chromogenic culture media for carbapenemase-producing Enterobacteriaceae. J Clin Microbiol 2012; 50: 3102-4.
37. Huang TD, Bogaerts P, Berhin C et al. Evaluation of Brilliance ESBL agar, a novel chromogenic medium for detection of extended-spectrum-blactamase-producing Enterobacteriaceae. J Clin Microbiol 2010; 48: 2091-6.
38. Edmond MB, Wenzel RP. Screening inpatients for MRSA-case closed. N Engl J Med 2013; 368: 2314-5.